Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000009/S133

Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T, Acticor 7 DR-T, Rivacor 7 DR-T, Rivacor 5 DR-T

Biotronik, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP000009/S133

What did the FDA decide?

The FDA database entry records a 30-day notice, designated OK30 and dated 2026-09-25, for P000009/S133, a supplement filed by Biotronik, Inc. under product code MRM (dual-chamber implantable defibrillator). The stated purpose is "to update manufacturing processes for high voltage capacitors in ICDs and CRT-Ds." This is a process change affecting manufacturing, not first-time market authorization for a new device.

The original PMA number P000009 establishes the supplement's lineage; S133 marks it as a later supplement rather than a separate approval of the full system. The notice concerns high voltage capacitors used in ICDs and CRT-Ds, but the source does not identify specific process parameters, supplier, affected models, or validation methods. The reported purpose is not evidence of safety or clinical effectiveness.

FDA approval order statement

to update manufacturing processes for high voltage capacitors in ICDs and CRT-Ds
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000009/S133
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
OK30
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P000009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000009 · Original PMA

    PHYLAX AV ICD SYSTEM

  2. P000009/S133 received

    Application receipt date recorded by FDA.

  3. P000009/S130 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T

  4. P000009/S124 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  5. P000009/S133 · FDA decision

    30-Day Notice

  6. P000009/S132 · Related supplement

    Acticor Sky DR-T 481987; Rivacor Sky DR-T 481982; Rivacor Rise DR-T 482018; Rivacor Aura DR-T 482014

  7. P000009/S134 · Related supplement

    Intica Neo 7 DR-T DF-1 ProMRI, Intica Neo 5 DR-T DF-1 ProMRI

  8. P000009/S135 · Related supplement

    Ilivia Neo 7 DRT, Intica Neo 7 DRT, Intica Neo 5 DRT, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aur

Timeline entries are records held by MedtechLedger for P000009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000009

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records